The U.S. and the world made a huge bet on Novavax, but manufacturing problems are jeopardizing billions of doses earmarked for poor and middle-income countries.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
